Minimal residual disease assessment in chronic lymphocytic leukaemia.

Minimal residual disease assessment in chronic lymphocytic leukaemia.

Item
http://www.wikidata.org/entity/Q36914093
Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia.Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencingFlow cytometry and polymerase chain reaction-based analyses of minimal residual disease in chronic lymphocytic leukemia.Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populationsHow and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters.Ultra-sensitive detection of rare T cell clones.
P2860

Minimal residual disease assessment in chronic lymphocytic leukaemia.

Item
http://www.wikidata.org/entity/Q36914093
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Minimal residual disease assessment in chronic lymphocytic leukaemia.
@en
Minimal residual disease assessment in chronic lymphocytic leukaemia.
@en-gb
type
label
Minimal residual disease assessment in chronic lymphocytic leukaemia.
@en
Minimal residual disease assessment in chronic lymphocytic leukaemia.
@en-gb
prefLabel
Minimal residual disease assessment in chronic lymphocytic leukaemia.
@en
Minimal residual disease assessment in chronic lymphocytic leukaemia.
@en-gb
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Minimal residual disease assessment in chronic lymphocytic leukaemia.
@en
P2093
P304
P31
P356
10.1016/J.BEHA.2007.03.004
P433
P478
P50
P577
P698
P921